Publication date: October 2026 Source: Research and Practice in Thrombosis and Haemostasis, Volume 10, Issue 7 Author(s): Danny M. Cohn, Henriette Farkas, Marc A. Riedl, Harsha Shetty, John-Philip Lawo, Maressa Pollen, H. Henry Li
Hemostatic function remains unaltered following therapeutic factor XIIa inhibition with garadacimab. // Research and Practice in Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2475037926036514?dgcid=rss_sd_all
Hemostatic function remains unaltered following therapeutic factor XIIa inhibition with garadacimab. Research and Practice in Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S2475037926036514?dgcid=rss_sd_all
“Hemostatic function remains unaltered following therapeutic factor XIIa inhibition with garadacimab.” Research and Practice in Thrombosis and Haemostasis.
@article{article64498,
title = {Hemostatic function remains unaltered following therapeutic factor XIIa inhibition with garadacimab},
journal = {Research and Practice in Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2475037926036514?dgcid=rss_sd_all}
}